Financhill
Sell
20

APLS Quote, Financials, Valuation and Earnings

Last price:
$19.58
Seasonality move :
14.26%
Day range:
$17.72 - $20.19
52-week range:
$17.72 - $57.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.11x
P/B ratio:
10.77x
Volume:
2.9M
Avg. volume:
2.3M
1-year change:
-64.42%
Market cap:
$2.5B
Revenue:
$781.4M
EPS (TTM):
-$1.59

Earnings Data

Next earnings date for APLS
May 07
2025
Most recent earnings per share
-$0.29
Beat by $0.12
(Feb 28/2025)
Consensus Estimate
-$0.41
(Feb 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

APLS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $211.8M -- -- -$0.25 --
05/07/2025 Q1 $197.6M -- -- -$0.34 --
02/28/2025 Q4 $197.9M $212.5M -$0.29 -$0.41 $0.12
11/05/2024 Q3 $199.8M $196.8M -$0.46 -$0.27 -$0.19
08/01/2024 Q2 $191.3M $199.7M -$0.30 -$0.32 $0.02
05/07/2024 Q1 $164.3M $172.3M -$0.54 -$0.41 -$0.13
02/27/2024 Q4 $143.6M $146.4M -$0.73 -$0.70 -$0.03
11/01/2023 Q3 -- -- -$1.17 -$0.99 -$0.18
07/31/2023 Q2 -- -- -$1.02 -$1.34 $0.32
05/04/2023 Q1 -- -- -$1.56 -$1.46 -$0.10
02/21/2023 Q4 -- -- -$1.50 -$1.45 -$0.05
11/07/2022 Q3 -- -- -$1.75 -$1.43 -$0.32
08/08/2022 Q2 -- -- -$1.46 -$1.36 -$0.10
05/04/2022 Q1 -- -- -$1.42 -$1.19 -$0.23
02/28/2022 Q4 -- -- -$1.53 -$1.60 $0.07
11/08/2021 Q3 -- -- -$2.28 -$1.57 -$0.71
08/09/2021 Q2 -- -- -$2.72 -$1.66 -$1.06
04/28/2021 Q1 -- -- -$2.32 -$1.76 -$0.56
02/25/2021 Q4 -- -- $1.06 -$1.37 $2.43
11/02/2020 Q3 -- -- -$1.79 -$1.56 -$0.23
07/31/2020 Q2 -- -- -$1.57 -$1.35 -$0.22
05/08/2020 Q1 -- -- -$2.29 -$1.43 -$0.86
02/27/2020 Q4 -- -- -$2.11 -$1.16 -$0.95
11/05/2019 Q3 -- -- -$1.10 -$1.04 -$0.06
07/31/2019 Q2 -- -- -$0.98 -$0.74 -$0.24
05/08/2019 Q1 -- -- -$0.84 -$0.62 -$0.22
02/26/2019 Q4 -- -- -$0.65 -$0.68 $0.03
11/13/2018 Q3 -- -- -$0.63 -$0.69 $0.06
07/31/2018 Q2 -- -- -$0.61 -$0.42 -$0.19
04/30/2018 Q1 -- -- -$0.43 -$0.33 -$0.10
03/19/2018 Q4 -- -- -$0.60 -$0.48 -$0.12
09/30/2017 Q3 -- -- -$0.23 -$0.24 $0.01

Apellis Pharmaceuticals Earnings Questions

  • How Much did Apellis Pharmaceuticals Generate in Revenue Last Quarter?

    Apellis Pharmaceuticals reported $212.5M worth of top line sales in its most recent quarter.

  • Did Apellis Pharmaceuticals Beat Earnings Last Quarter?

    Apellis Pharmaceuticals announced earnings per share of -$0.29 which represents a beat of analyst forecast a -$0.41 per share.

  • Is Apellis Pharmaceuticals Profitable?

    Apellis Pharmaceuticals reported $171.7M that represents $1.38 per share over the last quarter.

  • What is the Analyst Consensus for Apellis Pharmaceuticals EPS Next Year?

    Apellis Pharmaceuticals's earnings are forecast to decrease from -$1.60 per share to -$1.73 per share next year representing a decrease of -33.3%.

  • When is Apellis Pharmaceuticals's Earnings Date?

    Apellis Pharmaceuticals's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is up 43.59% over the past day.

Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is up 39.42% over the past day.

Sell
47
FNGO alert for Apr 10

MicroSectors FANG+ Index 2X Leveraged ETN [FNGO] is up 27.34% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock